Biogen Finalizes Apellis Takeover - Poll - MDSpire

Biogen Finalizes Apellis Takeover

Biogen closes its takeover of Apellis, gaining SYFOVRE and EMPAVELI while expanding its rare disease and kidney disease portfolio

  • June 8, 2026

  • 2 min

Share

Original Source(s)

Biogen Finalizes Apellis Takeover

  • June 8, 2026

Related Content

Safety signals of perfluorohexyloctane ophthalmic solution in patients with dry eye disease

Insights into the quality and guideline consistency of dry eye disease treatment videos on Chinese short-video platforms

Case Report: Novel FOXC1 variant c.311T>G (p.Ile104Ser) in a Chinese family with Axenfeld-Rieger syndrome